Turkey
GENKORD, founded in 2003, is a pioneering biotechnology entity operating in the niche sector of cord blood and stem cell banking. The company, based in Turkey, specializes in enhancing medical research and treatment through its focus on preserving valuable stem cells from newborns.
The firm's contributions to biotechnology research are bolstered through collaborations with numerous renowned institutions and scientists. Notably, GENKORD has received support from Tübitak and engaged in tissue engineering initiatives with the Hacettepe University Bioengineering Department. Additionally, it offers cryopreservation services tailored to specific needs, reflecting its versatility and commitment to advancing medical sciences.
Operating in the intersection of Biotechnology and Banking, the company remains a promising venture for investors interested in biotech advancements. However, it's noteworthy that GENKORD hasn't attracted recent investments, which could be a focal point for potential funding strategies and future growth opportunities.
